To: Board of Supervisors
From: Anna Roth, Health Services Director
Report Title: Amendment to Purchase Order with Abbott Laboratories
?Recommendation of the County Administrator ? Recommendation of Board Committee
RECOMMENDATIONS:
APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, an amendment to blanket purchase order #023253 with Abbott Laboratories to increase the payment amount by $150,000 to a new payment limit of $300,000 and Third Amendment to the Abbott Point of Care Agreement to purchase reagents and supplies needed for the I-Stat and I-Stat Alinity Handheld Analyzers for the Clinical Laboratory at the Contra Costa Regional Medical Center (CCRMC), and extend the term through November 18, 2027.
FISCAL IMPACT:
Approval of this action will result in additional expenditures of up to $150,000 over the period from September 1, 2021 through November 18, 2027 and funded 100% by Hospital Enterprise Fund I Revenues.
BACKGROUND:
CCRMC has used Abbott Laboratories since 2015. Abbott is CCRMC's primary supplier for the cartridges for point of care lactic acid and traumatic brain injury (TBI) testing. Abbott Laboratories is the sole manufacturer and distributor of the I-Stat Alinity Analyzer reagents used for TBI testing. No other vendor produces nor is authorized to distribute these products.
On August 31, 2021, the Purchasing Agent executed purchase order 023253 with Abbott Laboratories in the amount of $150,000 for the purchase of lactic acid testing cartridges for the period from September 1, 2021 through August 31, 2024.
CCRMC's current i-Stat analyzers are reaching end of their life cycle. Delays were due to product reviews and discussions regarding upgrading current instruments in conjunction with capabilities to integrate with Epic Beaker system, the new Laboratory Information System.
CONSEQUENCE OF NEGATIVE ACTION:
If this action is not approved, the Clinical Laboratory will not be able to re...
Click here for full text